This Barbie is going to be a mother. And Margot Robbie has no problem putting her burgeoning baby bump on full display. In fact, the Barbie star, who is pregnant with her Tom Ackerley’s first baby, debuted recently her bump while vacationing on Italy’s Lake Como with her husband July 7. For the outing, Margot donned a black blazer over a white tee that was cropped above her stomach, showing off a sweet baby bump. She finished off the look with low-rise black trousers, black platform sandals and a summery straw bag. For his part, Tom—whom Margot wed in a 2016 ceremony in her native Australia—wore olive green trousers and a cream-colored button-down shirt and tan sneakers. The couple were photographed waiting on a dock in Lake Como before they hopped in a boat and sailed off into a literal sunset. While Margot and Tom, both 34, haven’t spoken publicly about their upcoming bundle of joy, the I, Tonya alum has previously expressed hope to have a big family one day. As she told Porter in 2018, “If I'm looking into my future 30 years from now, I want to see a big Christmas dinner with tons of kids there.” Tom and Margot’s new chapter comes over ten years after their love story first began on the set of 2014's Suite Française, in which Margot starred while Tom worked as a third assistant director. But while she was immediately smitten, Margot was convinced her love would go unrequited. "I was always in love with him, but I thought, ‘Oh, he would never love me back,'" she admitted to Vogue in 2016. "'Don't make it weird, Margot. Don't be stupid and tell him that you like him.' And then it happened, and I was like, ‘Of course we're together. This makes so much sense, the way nothing has ever made sense before.'"

NEW DELHI, July 9 (Reuters) - India's beleaguered Paytm (PAYT.NS), opens new tab has secured approval from a government panel that oversees investments linked to China to invest 500 million rupees ($6 million) in a key subsidiary, three sources with direct knowledge of the matter said. The approval, which still has to be vetted by the finance ministry, will remove the main stumbling block to the unit, Paytm Payment Services, resuming normal business operations. Paytm Payment Services is one of the biggest remaining parts of the fintech firm's business, accounting for a quarter of consolidated revenue in the financial year ended March 2023. A separate unit, Paytm Payments Bank, was wound down this year by order of the central bank due to persistent compliance issues, triggering a meltdown in Paytm's stock. The government panel had earlier held back approval due to concerns about the 9.88% stake in Paytm held by China's Ant Group. India has intensified scrutiny of Chinese businesses since a 2020 border clash between the two countries. All in all, Paytm has been waiting for the nod from the government panel for about two years and without it, it would have had to also wind down its payment services business, which was forbidden from taking on new customers in March 2023. Once the approval has been formalised, it will be able to seek a so-called "payment aggregator" licence from the Reserve Bank of India. The sources, two of whom are government sources, declined to be identified as the decision has not been formally announced. India's foreign, home, finance and industries ministries, whose representatives sit on the panel, did not reply to emails seeking comment. A Paytm spokesperson said the company does not comment on market speculation. "We will continue to make disclosures in compliance with our obligations under the SEBI Regulations, and will inform the exchanges when there is any new material information to share," the spokesperson said.

On July 8, Ukrainian President Zelensky, who was visiting Poland, and Polish Prime Minister Tusk signed a bilateral security agreement in Warsaw, the capital of Poland. The agreement clearly states that Poland will provide support to Ukraine in air defense, energy security and reconstruction. After signing the agreement, Tusk said that the agreement includes actual bilateral commitments, not "empty promises." Previously, the United States, Britain, France, Germany and other countries as well as the European Union signed similar agreements with Ukraine.

The returner of the Chang'e-6 lunar probe is opened during a ceremony at the China Academy of Space Technology under the China Aerospace Science and Technology Corporation in Beijing, capital of China, June 26, 2024. The returner of the Chang'e-6 lunar probe was opened at a ceremony in Beijing on Wednesday afternoon. During the ceremony at the China Academy of Space Technology under the China Aerospace Science and Technology Corporation, researchers opened the returner and examined key technical indicators. Photo: Xinhua As the US space industry recently faced yet more delays and stagnation with key components including manned spacecraft and space suits "going wrong," NASA has once again resorted to its "sour grapes" rhetoric upon seeing China's successful retrieval of fresh lunar soils from the far side of the moon, by claiming that China did not directly invite its scientists to participate in the lunar soil research. This behavior is a typical blame-shifting trick, Chinese experts said, noting it is clear to all that it is the US' own laws, not China, that are restricting space cooperation between the two sides. Instead of deceiving themselves by distorting the truth, the US should face up to its own problem of overall weakening engineering capability and the lack of long-term planning in its space industry. After the Chang'e-6 samples, weighing nearly 2 kilograms, were safely transported to a special laboratory for further study on Friday, NASA spokesperson Faith McKie told media that while China worked with the European Space Agency, France, Italy and Pakistan on this mission, "NASA wasn't invited to take part in the moon probe." NASA also didn't get "any direct invitation" to study China's moon rocks, after it welcomed all scientists from around the world to apply to study them, McKie told NatSec Daily. Responding to the remarks, Chinese Foreign Ministry spokesperson Mao Ning told the Global Times on Monday that China is open to having space exchanges with the US, and we also welcome countries around the world to take part in the study of lunar samples. "However, the US side seems to have forgotten to mention its domestic legislation such as the Wolf Amendment. The real question is whether US scientists and institutions are allowed by their own government to participate in cooperation with China," Mao said. "The existence of the Wolf Amendment has basically shut the door to space collaboration between the two countries," Wang Yanan, chief editor of Beijing-based Aerospace Knowledge magazine, told the Global Times on Monday. Even if research institutions of the US have the willingness to work with China on opportunities such as lunar sample research, institutions there must obtain special approval from the US Congress due to the presence of this amendment, Wang explained. Currently, no such "green light" is in sight from the Congress. Furthermore, China's collaboration with international partners is based on equality and mutual benefit, leveraging their respective scientific resources, facilities, and expertise. However, the US only wants what it doesn't have, and its engagement with China would be advantageous only to itself, Wang noted. NASA has found itself embroiled in a number of thorny issues recently, with the latest being Boeing's Starliner manned spaceship experiencing both helium leaks and thruster issues during a June 6 docking with the International Space Station (ISS), which led to an indefinite delay for its crew's return to Earth, despite NASA's insistence that they are not "stranded" in space. The return of the Starliner capsule, while has already been delayed by two weeks, will be put on hold "well into the summer" pending results of new thruster tests, which are scheduled to start Tuesday and will take approximately two weeks or even more, per NASA officials. Previously on June 24, NASA cancelled a spacewalk on the ISS following a "serious situation," when one of the spacesuits experienced coolant leak in the hatch. While being broadcast on a livestream, the astronauts reported "literally water everywhere" as they were preparing for the extravehicular activity, space.com reported. The report said that this is the second time this particular spacewalk was postponed, after a June 13 attempt with a different astronaut group was pushed back due to a "spacesuit discomfort." The recurring issues with the spacesuits are due to their much-extended service lifespan, media reported, as the puffy white ones US astronauts currently wear were designed more than 40 years ago. Despite the pressing need to replace them, NASA announced recently that it is abandoning a plan to develop next-generation spacesuits, which had been committed to be delivered by 2026, CNN reported on Thursday. One of the root causes for such problems is that the US has developed many large technology conglomerates, which for a long time have benefited significantly from government orders and industry monopolies. Consequently, in many complex engineering fields, the level of attention given is greatly insufficient, Wang noted. It also reflected the US' lack of long-term strategic planning for its manned space program. For instance, the ageing spacesuits should have been replaced a decade ago to ensure that operational suits remain in usable condition. Failure to address this issue results in a hindrance to the space station's necessary maintenance tasks and even poses life-threatening risks to astronauts in emergency situations, experts said. The issues with Boeing's spacecraft and the spacesuits are not isolated problems, but reflected a systemic issue in the US space industry - the overall weakening of engineering capabilities, they noted.

China is mulling over establishing a Brain-Computer Interface (BCI) standardization technical committee under its Ministry of Industry and Information Technology (MIIT), aiming to guide enterprises to enhance industrial standards and boost domestic innovation. The proposed committee, revealed by the MIIT on Monday, will work on composing a BCI standards roadmap for the entire industry development as well as the standards for the research and development of the key technologies involved, according to the MIIT. China has taken strides in developing the BCI industry over the years, not only providing abundant policy support but also generous financial investment, Li Wenyu, secretary of the Brain-Computer Interface Industrial Alliance, told the Global Times. From last year to 2024, both the central and local governments have successively issued relevant policies to support industrial development. The MIIT in 2023 rolled out a plan selecting and promoting a group of units with strong innovation capabilities to break through landmark technological products and accelerate the application of new technologies and products. The Beijing local government also released an action plan to accelerate the industry in the capital (2024-2030) this year. In 2023, there were no fewer than 20 publicly disclosed financing events for BCI companies in China, with a total disclosed amount exceeding 150 million yuan ($20.6 million), Li said. “The strong support from the government has injected momentum into industrial innovation.” The fact that China's BCI industry started later than Western countries such as the US is a reality, leading to the gap in China regarding technological breakthroughs, industrial synergy, and talent development, according to Li. To further close gaps and solve bottlenecks in BCI industrial development, Li suggested that the industry explore various technological approaches to suit different application scenarios and encourage more medical facilities powered by BCI to initiate clinical trials by optimizing the development of BCI-related ethics. Additionally, he highlighted that standard development is one of the aspects to enhance the overall level and competitiveness of the industry chain, which could, in turn, empower domestic BCI innovation. While China's BCI technology generally lags behind leading countries like the US in terms of system integration and clinical application, this has not hindered the release of Neucyber, which stands as China's first "high-performance invasive BCI." Neucyber, an invasive implanted BCI technology, was independently developed by Chinese scientists from the Chinese Institute for Brain Research in Beijing. Li Yuan, Business Development Director of Beijing Xinzhida Neurotechnology, the company that co-developed this BCI system, told the Global Times that the breakthrough of Neucyber could not have been achieved without the efforts of the institute gathering superior resources from various teams in Beijing. A group of mature talents were gathered within the institute, from specific fields involving electrodes, chips, algorithms, software, and materials, Li Yuan said. Shrugging off the outside world's focus on China’s competition with the US in this regard, Li Yuan said her team doesn’t want to be imaginative and talk too much, but strives to produce a set of products step by step that can be useful in actual applications. In addition, Li Wenyu also attributed the emergence of Neucyber to the independent research atmosphere and the well-established talent nurturing mechanism in the Chinese Institute for Brain Research. He said that to advance China’s BCI industry, it is necessary not only to cultivate domestic talents but also to introduce foreign talents to enhance China's research and innovation capabilities. The proposed plan for establishing the BCI standardization technical committee under the MIIT will solicit public opinions until July 30, 2024.